Lupin launched the new Mycophenolate Mofetil 500mg tablets that will be used to help prevent the body from rejecting organ transplant. It is a generic equivalent of CellCept tablets of Roche Palo Alto LLC. It is stipulated for the prophylaxis of organ rejection in recipients of allogeneic kidney, heart or liver transplants & should be used in combination with other immunosuppressants. Lupin announced the launched after Concord Biotech received an approval from the United States Food and Drug Administration.